Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma

Name: Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

recurrent glioblastoma, idh-wildtype, recurrent gliosarcoma, recurrent who grade 4 glioma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 226252
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.